This 1 hour accredited program will help pharmacists review best-practice management of medicines used in the management of PsA and will help you identify patients who may require re-assessment by their prescriber. Recognising when PsA is sub-optimally controlled and identifying patients who require prompt referral to a rheumatologist for escalation of treatment (including newer oral agents) will help control disease and help prevent progressive joint damage.
Upon completion of this program, participants will be able to:
- Identify patients with psoriatic arthritis (PsA) who may require treatment optimisation and/or intensification due to the negative impact of treatment with DMARDs on their quality of life
- Individualise management of PsA patients by considering how a variety of factors, including safety, adverse effects of treatment and convenience of treatment regimens, may impact treatment targets
- Recognise the role pharmacists can play in encouraging and empowering patients to ask GPs and/or specialists about newer treatment options in PsA
- Counsel and engage their patients with PsA regarding adherence to treatment through exploring patient beliefs, attitudes, goals and preferences